Henrik Horndalsveen

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

University of Oslo(Current)

Oslo University Hospital

Henrik Horndalsveen is an author at University of Oslo specializing in malignant pleural mesothelioma immunotherapy, immune checkpoint combination therapy, and personalized immunotherapy.

ORCID

Publications per year

2021–2022

Publications

NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma

Vilde Drageset Haakensen, Anna K. Nowak, Espen B. Ellingsen et al. · Journal of Translational Medicine · 2021 · 23 citations · Full text

Life Sciences, Immunology, Oncology +17

Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and <scp>ctDNA</scp> responses—the <scp>ComIT</scp> ‐1 trial

Henrik Horndalsveen, Tine Norman Alver, Astrid Marie Dalsgaard et al. · Molecular Oncology · 2022 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–2 of 2